News
AXLA
0.3333
-4.50%
-0.0157
Axcella Health (AXLA) Gets a Hold from H.C. Wainwright
TipRanks · 05/08 10:35
BRIEF-Axcella Reports First Quarter Financial Results
Reuters · 05/04 22:25
Axcella Health GAAP EPS of -$0.05 beats by $0.11
Seeking Alpha · 05/04 21:33
Axcella Health Q1 EPS $(0.05) Beats $(0.16) Estimate
Benzinga · 05/04 21:13
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 04/18 17:14
Big Bank's Big Q1 Performance, Florida Gov. Quietly Slips 6-Week Abortion Ban Into Law, Subway Sandwich Seeks $10B Sale: Today's Top Stories
Benzinga · 04/14 14:01
H.C. Wainwright Keeps Their Hold Rating on Axcella Health (AXLA)
TipRanks · 04/03 10:25
Noble Financial Keeps Their Buy Rating on Axcella Health (AXLA)
TipRanks · 03/31 12:17
Axcella Health GAAP EPS of -$0.33 misses by $0.04
Seeking Alpha · 03/30 13:12
BRIEF-Axcella Reports Fourth Quarter And Full Year 2022 Financial Results
Reuters · 03/30 12:19
Axcella Health Q4 EPS $(0.33) Misses $(0.30) Estimate; Cash & Cash Equivalents Of Sufficient To Operate Into Q2 Of 2023
Benzinga · 03/30 12:13
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 03/08 21:31
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 02/20 13:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 02/17 17:30
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 02/17 17:26
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/17 13:06
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/17 12:39
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 02/16 21:31
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 02/16 18:12
More
Webull provides a variety of real-time AXLA stock news. You can receive the latest news about Axcella Health through multiple platforms. This information may help you make smarter investment decisions.
About AXLA
Axcella Health Inc. is a clinical-stage biotechnology company. The Company is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple biological pathways. Its pipeline includes lead therapeutic candidates for the treatment of Long COVID (also known as Post-COVID-19 Condition and Post-Acute Sequelae of COVID-19 (PASC)) associated fatigue, and the treatment of non-alcoholic steatohepatitis (NASH). AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy (OHE) recurrence in adult patients with liver cirrhosis. AXA1125 is also being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1125 is an oral product candidate that contains six amino acids and derivatives.